Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CNMD | STE |
|---|---|---|
| Price | $47.33 | $211.07 |
| Change today | ▲ 2.18% | ▲ 1.21% |
| Market cap | $1.42B | $20.58B |
| Return, 3 months | +38.2% | -1.7% |
| Return, year to date | +16.6% | -16.0% |
| Return, 1 year | +1.9% | -11.3% |
| P/E (TTM) | 25.6 | 25.8 |
| P/B | 1.4 | 2.9 |
| P/E percentile vs own 5y | – | 11th |
| Dividend yield | 0.42% | 1.19% |
| Revenue growth (YoY, latest qtr) | – | +7.3% |
| Net profit growth (YoY) | – | +12.9% |
| Gross margin | – | 44.4% |
| Operating margin | – | 18.9% |
| Net margin | – | 13.3% |
| Return on equity | – | 11.4% |
| Analyst target vs. price | – | +28.5% |
| Analyst buy share | – | 75% |
| RSI (14) | 54 | 43 |
| 30-day volatility | 25.7% | 15.6% |
| Max drawdown, 1 year | -34.2% | -25.4% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
